85% of Healthcare CIOs Now Treat Interoperability as AI Prerequisite, Not Compliance

Budget Priority Shift Creates New Vendor Requirements

Healthcare and public health agency leaders have fundamentally reframed how they budget for interoperability infrastructure. Research from Snowflake and Hakkoda reveals 85% of organizations now prioritize improving data sharing and interoperability more than they did two years ago — not for regulatory compliance, but to scale AI initiatives. The mechanism matters: organizations discovered that fragmented clinical data blocks AI model training and deployment, forcing interoperability upgrades from a compliance checkbox to a technical prerequisite.

This creates immediate procurement implications. Healthcare CIOs previously evaluated interoperability vendors on FHIR compliance and EHR integration speed. Now they filter first for API-first architectures, real-time data exchange, and built-in governance for sensitive patient data used in AI training. Vendors selling legacy hub-and-spoke interoperability models will lose deals to platforms demonstrating native integration with modern data clouds.

AI Investment Timeline Accelerates Data Platform Decisions

The same research shows 77% of healthcare organizations have already invested or plan to invest in generative or agentic AI technologies. Priority use cases center on administrative workflow automation, clinical documentation, and revenue cycle operations — all domains requiring unified patient data from multiple source systems. Organizations cannot deploy these AI applications without first consolidating fragmented data from Epic, Allscripts, athenahealth, Oracle, and departmental systems into a single analytical environment.

This sequence matters for buying timelines. Healthcare organizations historically approached interoperability projects on 18-24 month cycles tied to regulatory deadlines. AI deployment pressures compress this timeline. When a health system commits to AI-powered clinical documentation, the interoperability infrastructure must be operational within months, not years, to deliver ROI. Expect procurement cycles for data platforms and interoperability middleware to accelerate accordingly.

Market Growth Reflects Infrastructure Investment Wave

The healthcare data interoperability market reached $4.37 billion in 2025 and projects to $15.13 billion by 2035, representing 14.7% annual growth. This growth rate exceeds typical healthcare IT categories because it captures two spending streams: ongoing EHR integration work and new data platform infrastructure to support AI workloads. Organizations are not choosing between these investments — they are funding both simultaneously.

The competitive landscape is shifting in response. Point interoperability vendors like Redox, Rhapsody, and Lyniate compete for EHR integration work. Data platform vendors like Snowflake, Databricks, and Google Cloud position as the analytical layer where unified clinical data enables AI applications. Healthcare buyers increasingly evaluate these as connected purchases rather than separate categories. An organization selecting a new data platform will ask which interoperability middleware integrates natively. An organization purchasing interoperability tools will require API access to feed modern data warehouses, not just operational data stores.

What to Watch

Healthcare CIOs should pressure interoperability vendors to demonstrate specific AI-readiness capabilities: real-time data pipelines that support model inference, data governance frameworks that handle patient consent at scale, and API performance that meets latency requirements for clinical decision support applications. The 85% priority shift means vendors claiming general AI compatibility without these specifics will not survive RFP short lists.

For enterprise buyers in adjacent industries — financial services, life sciences, public sector — this signals what happens when AI deployment exposes data integration gaps. The pattern repeats: organizations discover that AI projects fail not because of model quality but because training data remains siloed across incompatible systems. Healthcare organizations solved this by elevating interoperability budgets and demanding AI-native architectures. Expect similar pressure in any regulated industry attempting to scale AI on fragmented legacy data.